Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in Italy

Abstract Background Age-related macular degeneration (AMD) is a common and chronic eye condition characterized by the presence of progressive degenerative abnormalities in the central retina (macula). Notably, neovascular, or wet, AMD (nAMD) occurs when new, abnormal blood vessels grow under the mac...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nicola Ferrante, Daniela Ritrovato, Rossella Bitonti, Gianluca Furneri
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2022-04-01
Colecção:BMC Health Services Research
Assuntos:
Brolucizumab
Neovascular age-related macular degeneration
nAMD
Cost-effectiveness
Acesso em linha:https://doi.org/10.1186/s12913-022-07972-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados